首页> 外国专利> EARLY DIAGNOSTIC METHOD FOR DISSEMINATED INTRAVASCULAR COAGULATION SYNDROME BY HUMAN TISSUE FACTOR ANTIGEN MEASUREMENT

EARLY DIAGNOSTIC METHOD FOR DISSEMINATED INTRAVASCULAR COAGULATION SYNDROME BY HUMAN TISSUE FACTOR ANTIGEN MEASUREMENT

机译:人组织因子抗原测定的血管内凝血综合征早期诊断方法。

摘要

PURPOSE: To early diagnose disseminated intravascular coagulation syndrome (DIC) and DIC preparing state by immunologically measuring a tissue factor(TF) in human blood or urine by use of a monochronal antibody for specifically identifying the TF. ;CONSTITUTION: A subject such as blood plasma or serum, or urine provided for TF immunological measurement is preliminarily treated with a surfactant to enhance the measuring sensitivity of TF antigen quantity. As the surfactant, non-ionic surfactants are used, and the subjected is treated at a critical miscell concentration or more. As the immunological method, sandwich method using two kinds of monochronal antibodies specifically identifying TF is adapted, and streptoavidin-HRP-biotinated tyramide composite method obtained by improving a conventional coloring system is used. As the judgment standard for occurrence prediction of DIC, the subject exceeding the average in measurement value of the subject of healthy man +2SD (standard deviation) and the subject in which the TF antigen in blood exceeds about 160pg/ml are judged to have a large possibility of occurrence of DIC.;COPYRIGHT: (C)1994,JPO&Japio
机译:目的:通过对人血液或尿液中的组织因子(TF)进行免疫学测定,并利用特异性鉴定该因子的单时抗体来早期诊断弥散性血管内凝血综合征(DIC)和DIC的制备状态。 ;组成:血浆,血清或尿液等用于TF免疫学测定的受试者,预先用表面活性剂处理,以提高TF抗原量的测量敏感性。作为表面活性剂,使用非离子表面活性剂,并以临界的混合比容浓度以上对被处理物进行处理。作为免疫学方法,采用了使用特异性识别TF的两种单时抗体的夹心法,并且使用了通过改良常规的显色系统而获得的链霉亲和素-HRP-生物素化的酪酰胺复合法。作为DIC的发生预测的判定标准,将超过健康人的测定值的平均值+ 2SD(标准偏差)的受试者和血液中的TF抗原超过约160pg / ml的受试者判定为“正常”。发生DIC的可能性很大。版权所有:(C)1994,JPO&Japio

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号